chemical catalysts having activities that can be switched off
and on by precipitation and redissolution based on reaction
temperature.8,9 In addition, these polymers are useful in
syntheses using biological catalysts.10 Most pertinent to the
described studies herein are previous uses of PNIPAM-
derived thermoresponsive polymers to purify known proteins.
An imidazole-PNIPAM thermoresponsive polymer loaded
with Cu(II) ions was used for the affinity purification of
proteins from cereals (Figure 1).11 PNIPAM coupled to an
ings, derived from coupling of a representative hydrophobic
natural product derivative, dexamethasone (Dex), and a repre-
sentative hydrophilic natural product, cyclosporin A (CsA),
to a copolymer of N-isopropyl acrylamide and N-(acroyloxy)-
succinimide (PNIPAM-NASI). In addition, a pull-down
experiment with the CsA macroligand demonstrates the
utility of these soluble macroligands in affinity experiments.
The synthesis of dexamethasone macroligands 4a-d
commenced with the known R-hydroxy acid derivative 217
that was coupled with mono-N-Boc-1,9-diaminoundecane
providing amide 3a (Scheme 1). Following Boc deprotection
Scheme 1. Synthesis of Dexamethasone Macroligands
Figure 1. PNIPAM-derived macroligands previously employed for
protein purification.
iminobiotin affinity ligand was used to isolate a lysozyme
from fetal calf sera.12 In connection with our interest in
coupling natural products to their cellular receptors,13 we
considered the attachment of natural products to PNIPAM
polymers to facilitate characterization of the immobilized
natural product.14
Affinity chromatography is based on the principle of
specific protein-ligand interactions and is a common tool
for purification of proteins, antibodies, and receptor-ligand
complexes.15 However, traditional affinity chromatography
techniques are plagued by nonspecific binding of proteins
due to physical inclusion as a result of the solid state of the
matrix and nonspecific interactions with the polymer back-
bone. In addition, it is typically not possible to assess the
integrity of the natural product ligand following coupling to
the insoluble matrix. In efforts to minimize these limitations,
we considered the use of the soluble polymer, PNIPAM, for
attachment of natural product ligands for isolation of their
cellular receptors. There are several possible advantages of
using PNIPAM. The parent polymer is soluble in aqueous
solution at 4 °C and has an LCST of 32 °C. The LCST can
be subtly increased or decreased by using more hydrophilic
or hydrophobic comonomers, respectively.16 This tactic could
be used for more sensitive proteins that are unable to
withstand higher LCSTs. Herein, we describe the synthesis
and properties of two macroligands, with various ligand load-
under standard conditions, the trifluoroacetate amine salt 3b
was coupled to the PNIPAM-NASI copolymer, available
by radical copolymerization.18 The remaining unreacted
N-acryloyloxy succinimide acid esters were capped by
addition of excess isopropyl amine to provide the macroli-
gands 4a-d with various ligand loadings, accomplished by
varying the stoichiometry of 3b (0.01, 0.04, 0.029, and
0.0075 equiv of 3b relative to the final N-iPr monomer,
respectively) added during the coupling step (Figure 2a). The
1
ratio of ligand to backbone monomer was verified by H
NMR analysis (Figure 2b).
The data in Figure 2 provide convincing evidence that
covalent attachment of dexamethasone occurred. First, the
water solubility of the polymer changes significantly.
Incorporation of larger amounts of the hydrophobic dexam-
ethasone lowered the water solubility of the product copoly-
mer as expected. If the dexamethasone had not been
incorporated as shown in Scheme 1, the NASI active esters
(8) Bergbreiter, D. E.; Zhang, L.; Mariagnanam, V. M. J. Am. Chem.
Soc. 1993, 115, 9295.
(9) Bergbreiter, D. E.; Caraway, J. W. J. Am. Chem. Soc. 1996, 118,
6092.
(10) Huang, X.; Witte, K. L.; Bergbreiter, D. E.; Wong, C.-H. AdV. Synth.
Catal. 2001, 343, 675.
(11) Kumar, A.; Galaev, I. Y.; Mattiasson, B. Bioseparation 1998, 7,
185.
(12) Garret-Flaudy, F.; Freitag, R. Biotechnol. Bioeng. 2000, 71, 223.
(13) Liu, J. O.; Low, W.-K.; Dang, Y.; Schneider-Poetsch, T.; Zanggao,
S.; Choi, N. S.; Romo, D.; Merrick, W. Mol. Cell 2005, 20, 709.
(14) (a) Affinity Chromatography: A Practical Approach; Dean, P. D.
G., Johnson, W. S., Middle, F. A., Eds.; IRL Press: Oxford, 1985. (b)
Scopes, R. K. Protein Purification: Principles and Practice, 3rd ed.;
Springer-Verlag: New York, 1994.
(16) (a) Taylor, L. D.; Cerankowski, L. D. J. Polym. Sci., Polym. Chem.
Ed. 1975, 13, 2551. (b) Mao, H.; Li, C.; Zhang, Y.; Furyk, S.; Cremer, P.
S.; Bergbreiter, D. E. Macromolecules 2004, 37, 1031.
(17) Lustenberger, P.; Formstecher, P.; Dautrevaux, M. J. Steroid
Biochem. Mol. Biol. 1981, 14, 697.
(18) Bergbreiter, D. E.; Hughes, R.; Besinaiz, J.; Li, C.; Osburn, P. L.
J. Am. Chem. Soc. 2003, 125, 8244.
(15) Cuatrecasas, P. J. Biol. Chem. 1970, 245, 3059.
5248
Org. Lett., Vol. 8, No. 23, 2006